What is myeloid sarcoma cancer?
Myeloid sarcoma (MS) is a rare, extramedullary tumor consisting of immature white blood cells of myeloid lineage. MS is usually associated with the concurrent diagnosis of acute myeloid leukemia (AML) but can also present in the absence of bone marrow disease or at relapse of AML.
Can acute myeloid leukemia be cured?
Although AML is a serious disease, it is treatable and often curable with chemotherapy with or without a bone marrow/stem cell transplant (see the Types of Treatment section).
What is the life expectancy of a person with leukemia?
Life expectancy for this kind of leukemia may be 10 years, 20 years or even longer. Leukemia life expectancy also depends on the type of blood cells affected by the cancer. There are two groups of leukemia: lymphocytic and myelogenous, which are further divided into sub-groups, each with differing survival rates.
How do I treat AML blood?
The standard treatment for AML includes high-dose chemotherapy with a cytarabine/anthracycline combination, followed by either one to four cycles of consolidation (postremission) chemotherapy, and stem cell transplantation, either using a patient’s own cells (autologous) or a donor’s cells (allogeneic).
What are the symptoms of acute myeloid leukemia?
Early symptoms of adult acute myeloid leukemia are often similar to those caused by the flu or other common illness and may include fever, shortness of breath, easy bruising or bleeding, petechiae (flat, pinpoint reddish-purple spots under the skin caused by bleeding), weakness or feeling tired,…
What is AML Leukemia survival?
The overall rate of survival for AML five years is 26%. This means that of the thousands of people living with AML, approximately 26% of the population still live five years after diagnosis. For the low-risk group of AML (acute myeloid leukemia), the survival rate of five years is 65%.
